Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Cremoni

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Kidney International Reports|April 14, 2025
Obinutuzumab and Ofatumumab are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab AntibodiesMaxime Teisseyre, Marco Allinovi, Vincent Audard, et al.
Eclinicalmedicine|December 1, 2025
The personalized approach to rituximab treatment in membranous nephropathy: a multi-center randomized controlled trialVesna Brglez, Maxime Teisseyre, Kévin Zorzi, et al.
Kidney International Reports|December 19, 2024
Anti Phospholipase A2 Receptor 1 Antibodies and Membranous Nephropathy Recurrence After Kidney TransplantationMarion Cremoni, Maxime Teisseyre, Olivier Thaunat, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Kidney International Reports|April 14, 2025
Obinutuzumab and Ofatumumab are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab AntibodiesMaxime Teisseyre, Marco Allinovi, Vincent Audard, et al.
Eclinicalmedicine|December 1, 2025
The personalized approach to rituximab treatment in membranous nephropathy: a multi-center randomized controlled trialVesna Brglez, Maxime Teisseyre, Kévin Zorzi, et al.
Kidney International Reports|December 19, 2024
Anti Phospholipase A2 Receptor 1 Antibodies and Membranous Nephropathy Recurrence After Kidney TransplantationMarion Cremoni, Maxime Teisseyre, Olivier Thaunat, et al.
Pageof 4